Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
34 participants
OBSERVATIONAL
2007-12-04
2024-04-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The relation between eye movement and brain function is a subject of interest to the National Eye Institute.
* By comparing eye movement in healthy volunteers to research conducted on patients who have difficulty moving their eyes, the National Eye Institute hopes to develop and improve diagnostic procedures for people with eye diseases.
Objectives:
-The purpose of this study is to understand how we see visual patterns and how we move our eyes to see.
Eligibility:
* Normal volunteers:
* must have no serious illnesses and must be 18 years of age or older
* are able to follow directions and pay attention to visual stimuli and respond as appropriate
* individuals with a history of eye or brain diseases, or previous eye or eye muscle surgery, are not allowed to participate in this study. Individuals who are currently using eye medications also are not eligible for the study.
* Patients:
* who are 18 years of age or older
* are able to follow directions and pay attention to visual stimuli and respond as appropriate
Design:
* Participants will visit the National Eye Institute outpatient clinic for examination and testing.
* Participants will be screened with a medical history and eye examination (including eye pressure and eye movement tests).
* Participants with healthy eyes will participate in eye movement testing experiments:
* One or more sessions lasting less than three hours each.
* Eye movements will be recorded with a video/infrared camera system.
* For the majority of the studies done under this protocol, only one or two sessions will be required. A few studies recording very small eye movements will require three or more sessions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Stimulus and Eye Movement
NCT00001172
Training to Modify Fixational Eye Movements for Optimizing Visual Performance in People With Central Vision Loss
NCT06670989
Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage
NCT05098236
Reading Problems Associated With Central Nervous System (CNS) Pathologies.
NCT04937725
Eye Movement Rehabilitation in Low Vision Patients
NCT04929756
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives:
The objective is to study normal volunteers and patients for eye movement and other responses to visual stimuli with the goal of better understanding human vision and neural control of eye movements.
Endpoints:
The primary outcome measure is eye movement and other responses to visual stimuli.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Volunteer
Healthy subjects without neurodegenerative diseases
No interventions assigned to this group
Patients
Subjects with neurodegenerative diseases
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Participant must be a volunteer with no ocular, visual, or oculomotor problems.
2. Participant must be 18 years old or older.
3. Participant must be able to follow directions and actively pay attention to visual stimuli and respond as appropriate.
4. For studies which use the contact lens, participant must be able to tolerate a contact lens in either one or both eyes.
In order to be eligible to participate in this study, an individual must meet all of the following criteria
1. Participant must be 18 years old or older.
2. Participant must be able to follow directions and actively pay attention to visual stimuli and respond as appropriate.
3. For studies which use the contact lens, participant must be able to tolerate a contact lens in either one or both eyes.
Exclusion Criteria
study:
An individual who meets any of the following criteria will be excluded from participation in thisstudy:
1. Participant has a history of ocular or visual diseases or diseases affecting the nervous system (including myasthenia, MS, etc.) or any diseases which might affect control of eye movements or affect vision.
2. Participant has had prior eye or eye muscle surgery.
3. Participant has a history of eye patching (amblyopia or lazy eye).
4. Participant currently uses eye drops or ocular medications.
An individual who meets any of the following criteria will be excluded from participation in this study:
1\. Patient is unable to cooperate with testing, including sitting still while eye movements are recorded.
18 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Eye Institute (NEI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rich J Krauzlis, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Eye Institute (NEI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-EI-0031
Identifier Type: -
Identifier Source: secondary_id
080031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.